Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

SSE Ticker: 603313

Healthcare Co., Ltd.

梦百合

Authorized Representative: 倪张根

Board: Main A

Industry Classification: Manufacturing

The dividend of the epidemic subsided, and the stable medical 752 million cross-border injection and puncture track-News Channel-Hexun.com

  • Post date May 20, 2022 — 17:40 Post Lock Login to View

Read More

Ni Zhanggen, chairman of Menglily, transferred 10.77% of the shares for 552 million yuan, and the local government rescued funds

  • Post date May 20, 2022 — 16:53 Post Lock Login to View

Read More

Hillhouse has won an IPO, laid out a pharmaceutical SMO, with a market value of over 4 billion – yqqlm

  • Post date May 17, 2022 — 12:22 Post Lock Login to View

Read More

Tongce Medical has exhausted 770 million bet medical informatization targets, and Heren Technology has deducted from a 10-year low and has become a shell Tongce Medical_Sina Finance_Sina.com

  • Post date May 17, 2022 — 10:48 Post Lock Login to View

Read More

Another case of "A buys A", Tongce Medical "huaguang" book funds to acquire Heren Technology

  • Post date May 17, 2022 — 02:18 Post Lock Login to View

Read More

Buy, buy, buy! Tongce Medical acquired Heren Technology for 770 million yuan, but Gelangjia’s “yamao” fell sharply – yqqlm

  • Post date May 17, 2022 — 02:17 Post Lock Login to View

Read More

More than 2.5 billion yuan! Public offering has set off a wave of self-purchasing, what signal does it release? -Funds Financial Sector

  • Post date May 17, 2022 — 01:51 Post Lock Login to View

Read More

More than 2.5 billion yuan! Public offering has set off a wave of self-purchasing, what signal does it release? -Funds Financial Sector

  • Post date May 17, 2022 — 01:51 Post Lock Login to View

Read More

Another case of "A buys A", Tongce Medical "huaguang" book funds to acquire Heren Technology

  • Post date May 17, 2022 — 00:57 Post Lock Login to View

Read More

Another case of "A buys A", Tongce Medical "Huaguang" acquired Heren Technology Tongce Medical with book funds_Sina Finance_Sina Network

  • Post date May 17, 2022 — 00:25 Post Lock Login to View

Read More

Buy, buy, buy! Tongce Medical’s 770 million acquisition of Heren Technology

  • Post date May 17, 2022 — 00:16 Post Lock Login to View

Read More

Buy, buy, buy! Tongce Medical's 770 million acquisition of Heren Technology

  • Post date May 17, 2022 — 00:00 Post Lock Login to View

Read More

Investors in the acquisition of Heren Technology exclaimed that they did not understand, Tongce Medical plunged 7.67%, hitting a two-year low 21 Economic Net

  • Post date May 16, 2022 — 23:44 Post Lock Login to View

Read More

A big news, the head real estate company immediately soared 15%

  • Post date May 16, 2022 — 21:13 Post Lock Login to View

Read More

Chinese brand Ridingdang Kuaiyao: technological innovation, digital drive, serving people's health with professional power

  • Post date May 16, 2022 — 14:11 Post Lock Login to View

Read More

Hexun SGI Index 2021 annual report list released! "Dark Horse" Baichu Electronics won the top spot, and Mindray Medical still ranks in the top three! -Stock Channel-Hexun.com

  • Post date May 16, 2022 — 10:02 Post Lock Login to View

Read More

Hexun SGI Index 2021 Annual Report TOP30 List Released! The top three on the list have changed a lot. Baichu Electronics won the top spot, while Montage Technology and others fell off the list.

  • Post date May 16, 2022 — 10:01 Post Lock Login to View

Read More

Hexun SGI Index 2021 Annual Report TOP30 List Released! The top three on the list have changed a lot. Bochu Electronics won the top spot, while Montage Technology and others fell on the list.

  • Post date May 16, 2022 — 10:00 Post Lock Login to View

Read More

Heavy analysis! Where did the core assets fall? Nearly half of the constituent stocks of the Mao Index fell by more than 50%, and many indexes retreated more than 2018. Some stocks have become the pioneers of rebound

  • Post date May 16, 2022 — 08:55 Post Lock Login to View

Read More

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

  • Post date May 16, 2022 — 08:44 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.